Nuvalent Cl A (NUVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NUVL | CYTK | ALKS | ||
| Company | Nuvalent Cl A | Cytokinetics | Alkermes Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 123.56 | 85.00 | 53.94 | ||
| High | 123.57 | 87.35 | 54.45 | ||
| Low | 123.46 | 84.51 | 52.23 | ||
| Latest | 123.51 | 87.26 | 52.53 | ||
| Change | -0.01 | +5.07 | -2.55 | ||
| % Change | -0.01% | +6.17% | -4.63% | ||
| Volume | 1,263,100 | 3,635,400 | 2,940,800 | ||
| 20-Day Average Volume | 5,340,650 | 2,456,870 | 2,750,655 | ||
| Previous Close | 123.52 | 82.19 | 55.08 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 113.79 | 74.80 | 45.76 | ||
| 20-Day Raw Stochastic | 99.51% | 99.57% | 81.27% | ||
| 20-Day Relative Strength | 63.87 | 70.29 | 73.83 | ||
| Weighted Alpha | +32.08 | +101.34 | +103.54 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 06/22/26 | +10.22% since 06/22/26 | +14.15% since 06/22/26 | ||
| Low | 123.41 on 06/23/26 | 78.27 on 06/23/26 | 45.47 on 06/23/26 | ||
| High | 123.69 on 06/26/26 | 87.35 on 06/29/26 | 55.28 on 06/26/26 | ||
| 1-Month | |||||
| %Chg | +11.89% since 05/29/26 | +13.68% since 05/29/26 | +24.51% since 05/29/26 | ||
| Low | 87.30 on 06/08/26 | 66.63 on 06/10/26 | 40.62 on 06/03/26 | ||
| High | 123.69 on 06/26/26 | 87.35 on 06/29/26 | 55.28 on 06/26/26 | ||
| 3-Month | |||||
| %Chg | +27.78% since 03/27/26 | +39.62% since 03/27/26 | +78.73% since 03/27/26 | ||
| Low | 87.30 on 06/08/26 | 58.65 on 04/29/26 | 29.15 on 03/30/26 | ||
| High | 123.69 on 06/26/26 | 87.35 on 06/29/26 | 55.28 on 06/26/26 | ||
| 6-Month | |||||
| %Chg | +21.37% since 12/29/25 | +41.31% since 12/29/25 | +87.54% since 12/29/25 | ||
| Low | 87.30 on 06/08/26 | 58.43 on 03/13/26 | 27.00 on 03/19/26 | ||
| High | 123.69 on 06/26/26 | 87.35 on 06/29/26 | 55.28 on 06/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,757,833 | 10,227,148 | 9,180,514 | ||
| Shares Outstanding, K | 78,998 | 124,433 | 166,676 | ||
| Annual Sales | 0 | 88,040,000 | 1,475,900,000 | ||
| Annual Net Income | -425,380,000 | -784,960,000 | 241,660,000 | ||
| Last Quarter Sales | 0 | 19,360,000 | 392,910,000 | ||
| Last Quarter Net Income | -109,280,000 | -206,030,000 | -66,480,000 | ||
| 60-Month Beta | 1.15 | 0.42 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.39 on 05/07/26 | -1.67 on 05/05/26 | -0.40 on 05/05/26 | ||
| Earnings Date | 08/06/26 | 08/06/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 57.98 | ||